These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 14604966)

  • 21. HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy.
    Li H; Nakashima H; Decklever TD; Nace RA; Russell SJ
    Cancer Gene Ther; 2013 Aug; 20(8):478-85. PubMed ID: 23868101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition.
    Touchefeu Y; Khan AA; Borst G; Zaidi SH; McLaughlin M; Roulstone V; Mansfield D; Kyula J; Pencavel T; Karapanagiotou EM; Clayton J; Federspiel MJ; Russell SJ; Garrett M; Collins I; Harrington KJ
    Radiother Oncol; 2013 Jul; 108(1):24-31. PubMed ID: 23849174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.
    Myers RM; Greiner SM; Harvey ME; Griesmann G; Kuffel MJ; Buhrow SA; Reid JM; Federspiel M; Ames MM; Dingli D; Schweikart K; Welch A; Dispenzieri A; Peng KW; Russell SJ
    Clin Pharmacol Ther; 2007 Dec; 82(6):700-10. PubMed ID: 17971816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
    Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
    J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
    Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
    Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.
    Peng KW; Donovan KA; Schneider U; Cattaneo R; Lust JA; Russell SJ
    Blood; 2003 Apr; 101(7):2557-62. PubMed ID: 12433686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.
    Msaouel P; Opyrchal M; Dispenzieri A; Peng KW; Federspiel MJ; Russell SJ; Galanis E
    Curr Cancer Drug Targets; 2018; 18(2):177-187. PubMed ID: 28228086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread.
    Ayala-Breton C; Suksanpaisan L; Mader EK; Russell SJ; Peng KW
    Mol Ther; 2013 Oct; 21(10):1930-7. PubMed ID: 23842448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
    Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
    Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer.
    Trujillo MA; Oneal MJ; McDonough S; Qin R; Morris JC
    Cancer Gene Ther; 2012 Dec; 19(12):839-44. PubMed ID: 23037808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
    Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
    Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
    Msaouel P; Dispenzieri A; Galanis E
    Curr Opin Mol Ther; 2009 Feb; 11(1):43-53. PubMed ID: 19169959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing cytokine-induced killer cell therapy of multiple myeloma.
    Liu C; Suksanpaisan L; Chen YW; Russell SJ; Peng KW
    Exp Hematol; 2013 Jun; 41(6):508-17. PubMed ID: 23403007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
    PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modeling of cancer radiovirotherapy.
    Dingli D; Cascino MD; Josić K; Russell SJ; Bajzer Z
    Math Biosci; 2006 Jan; 199(1):55-78. PubMed ID: 16376950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic measles virus retargeting by ligand display.
    Msaouel P; Iankov ID; Allen C; Russell SJ; Galanis E
    Methods Mol Biol; 2012; 797():141-62. PubMed ID: 21948475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.
    Packiriswamy N; Upreti D; Zhou Y; Khan R; Miller A; Diaz RM; Rooney CM; Dispenzieri A; Peng KW; Russell SJ
    Leukemia; 2020 Dec; 34(12):3310-3322. PubMed ID: 32327728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically targeted radiotherapy for multiple myeloma.
    Dingli D; Diaz RM; Bergert ER; O'Connor MK; Morris JC; Russell SJ
    Blood; 2003 Jul; 102(2):489-96. PubMed ID: 12649158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.